INVO Fertility, Inc. has taken a significant step by implementing a 1-for-4 reverse stock split, effective October 30, 2026. This decision is aimed at improving the company's stock price and overall market position. The reverse stock split will allow the company to consolidate its shares, which may enhance investor confidence and attract new investors.

As part of this change, every four shares of common stock will be combined into one share, without altering the par value per share. The company's authorized shares will also be adjusted to a total of 62,500,000 shares. The common stock will continue to trade on The Nasdaq Capital Market under the existing symbol 'IVF', with a new CUSIP number assigned.

Background

INVO Fertility, Inc. operates in the surgical and medical instruments and apparatus sector, as classified under SIC 3841. The company is listed on the Nasdaq under the ticker symbol IVF. INVO Fertility has undergone several name changes in its history, previously known as NAYA Biosciences, Inc. and INVO Bioscience, Inc.

What the Filing Says

The recent filing indicates, "The Reverse Stock Split became effective at 12:01 a.m., Eastern Time, on Friday, October 30, 2026, and the Company’s Common Stock began trading on a split-adjusted basis when The Nasdaq Stock Market opened on October 30, 2026." This statement highlights the operational timeline for the stock split and its immediate effect on trading.

Impact

This reverse stock split may affect current shareholders by adjusting their holdings and could influence potential investors' perceptions of the company's stability and growth potential. The adjustment in the number of shares outstanding may also impact the company's market capitalization and trading volume.

What's Next

The filing does not say what happens next.